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ABSTRACT 
Objective: To develop a simple and cheap UV spectrophotometric method for the quantitative estimation of Solifenacin succinate (5mg) in tablets 
and validate as per ICH guidelines.  
Methods: The optimized method uses a solvent 100% triethylammonium phosphate buffer (pH 2.5) for the estimation of assay of Solifenacin 
succinate in tablets at a detection wavelength of 215 nm.  
Results: The developed method resulted in Solifenacin succinate exhibiting linearity in the range 5-15μg/ml. The precision is exemplified by 
relative standard deviation of 1.27%. Percentage Mean recovery was found to be in the range of 98-102, during accuracy studies. The limit of 
detection (LOD) and limit of quantitiation (LOQ) were found to be 1.106µg/ml and 3.35µg/ml respectively. 
Conclusion: A simple and a cheap UV spectrophotometric method was developed and validated for the quantitative estimation of Solifenacin 
succinate in tablets as per ICH guidelines and hence it can be used for the routine analysis in various pharmaceutical industries.  
Keywords: UV, Solifenacin succinate, Method development, Validation. 
 
INTRODUCTION 
Solifenacin succinate (Figure 1) is a competitive muscarinic 
acetylcholine receptor antagonist. Muscarinic receptor antagonists 
are widely used for treatment of the syndrome of overactive bladder 
and urge urinary incontinence [1-4]. The binding of acetylcholine to 
these receptors, particularly the M3 receptor subtype, plays a critical 
role in the contraction of smooth muscle. By preventing the binding 
of acetylcholine to these receptors, Solifenacin reduces smooth 
muscle tone in the bladder, allowing the bladder to retain larger 
volumes of urine and reducing the number of incontinence episodes. 
IUPAC name of Solifenacin succinate is Butanedioic acid, compound 
with (1S)-(3R)-1-azabicyclo [2.2.2] oct-3-yl 3,4-dihydro-1-phenyl-
2(1H)-iso-quinolinecarboxylate (1:1), having an empirical formula of 
C23H26N2O2. C4H6O4 and a molecular weight of 480.55. It is freely 
soluble at room temperature in water, Glacial acetic acid, dimethyl 
sulfoxide and methanol [1-4]. 
 
Fig. 1: Structure of Solifenacin succinate 
 
Literature survey reveals chromatographic methods for the analysis of 
Solifenacin succinate in various pharmaceutical dosage forms [1-7]. Very 
few literature is cited on spectrophotometric methods [8-9]. Hence we 
here report a new, cheap, simple, accurate and precise UV method for the 
determination of assay of solifenacin succinate in SOLITEN tablets and 
validate the developed method as per ICH guidelines. 
MATERIALS AND METHODS 
Materials 
Instrument 
A double beam UV-visible spectrophotometer (Shimadzu, model 
1800) having two matched quartz cells with 1 cm light path and 
loaded with UV probe software (version 2.41) was used for 
recording of spectra and measuring absorbance. An electronic 
analytical weighing balance (0.1mg sensitivity, Shimadzu AY 220), 
digital pH meter (DELUX model 101) and a sonicator (sonica, model 
2200 MH) were used in this study.  
Chemicals and Reagents 
Analytically pure sample of Solifenacin succinate with purities 
greater than 99% was obtained as gift sample from RACHEM 
pharma, Hyderabad, India and tablet formulation [SOLITEN] was 
procured from MEDPLUS, Hyderabad, India with labelled amount 
5mg of Solifenacin succinate. Triethylamine (AR Grade) and ortho 
phosphoric acid (AR Grade) were obtained from SD Fine chemicals 
(Hyderabad, India). 0.45μm Nylon membrane filters were obtained 
from Spincotech Private Limited, Hyderabad, India. 
Method 
Solvent 
Solvent used is prepared by adding 5 ml of triethylamine to 1000 ml 
of distilled water and later pH was adjusted to 2.5 using 30% v/v of 
ortho phosphoric acid in water. Solvent was then filtered through 
0.45 μm nylon membrane filter.  
Selection of suitable detection wavelength 
Suitable wavelength for the total experiment was determined by 
recording UV spectrum in the range of 200-400 nm for Solifenacin 
succinate and suitable wavelength selected was 215 nm (Figure 2). 
Preparation of working standard solution 
10mg of Solifenacin succinate was accurately weighed and taken in 
100 ml clean and dry volumetric flask containing 80 ml of solvent 
and then the solution was made up to the mark using the solvent. 
This is considered as standard solution (10µg/ml), treated as 
working standard, 100% target concentration.  
Preparation of stock and working sample solution 
Ten tablets were weighed separately and the average weight wqas 
determined. The average weight was weighed from the ten tablets 
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grinded in a pestle and mortar, transferred to a 100 ml volumetric 
flask containing 100 ml diluent and then sonicated for 3 minutes, 
followed by filtration through 0.45µ nylon membrane filter to get 
sample stock solution of 50µg/ml. 2 ml of the above stock solution 
was pipetted out and made up to 10 ml to get working sample 
solution equivalent to a concentration of working standard of 10 
µg/ml. 
 
Fig. 2: UV spectrum of Solifenacin succinate 
 
RESULTS AND DISCUSSION 
Method Development 
Various solvents were explored, including Potassium dihydrogen 
orthophosphate, triethylammonium phosphate and ammonium 
acetate buffers varying pH in the ranges of 2-7. Solifenacin succinate 
was found to be soluble and stable for minimum of 1 hour at room 
temperature using pH 2.5 triethylammonium phosphate buffer and 
hence this buffer was initiated for the determination of suitable 
detection wavelength and working concentration of standard. In 
order to test the applicability of the developed method to a 
commercial formulation, SOLITEN was studied at working 
concentration. Absorbance and assay for working concentration of 
sample at 215 nm was in acceptance limits (98-102%) with the 
standard working concentration during extraction of drug in the 
sample using the solvent for 3 minutes. The protocol affords 
reproducible quantification of the drug in the sample ranging 
between 98 and 102%, which is the standard level in any 
pharmaceutical quality control. Hence the method is optimized.  
Method validation 
Validation of the analytical method is the process that establishes by 
laboratory studies in which the performance characteristics of the 
method meet the requirements for the intended analytical 
application. UV spectrophotometric method developed was 
validated according to International Conference on Harmonization 
(ICH) guidelines [10] for validation of analytical procedures. The 
method was validated for the parameters like linearity, accuracy, 
system precision, intra-day precision, inter-day precision/ 
intermediate precision/ ruggedness, robustness, limit of detection 
(LOD) and limit of quantitiation (LOQ). 
Precision 
System precision 
Six replicate recording of absorbance at 215 nm of standard solution 
at working concentration showed % RSD (Relative Standard 
Deviation) less than 2 concerning absorbance for the drug, which 
indicates the acceptable reproducibility and thereby the precision of 
the system. System precision results are tabulated in table 1. 
Method precision 
Method precision was determined by performing assay of sample 
under the tests of repeatability (Intraday precision) at working 
concentration.  
 
Table 1: System precision results of Solifenacin succinate. 






 Average 0.321 
 SD 0.0014 
 % RSD 0.43 
 
Table 2: Intraday precision results of Solifenacin succinate 







S. D. 1.273 
% RSD 1.277 
 
Table 3: Calibration data for Solifenacin succinate 








50 5 0.141 0.136 0.147 
75 7.5 0.233 0.228 0.240 
100 10 0.322 0.307 0.315 
125 12.5 0.393 0.378 0.386 
150 15 0.481 0.483 0.464 
Regression equation  y=0.033x-0.022 y=0.033x-0.031 y=0.031x-0.009 
Regression coefficient  0.998 0.996 0.997 
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Table 4: Results of Accuracy studies for Solifenacin succinate 




*Mean of three replicates 
 
Table 5: Robustness results of Solifenacin succinate sample 
Variation parameter Variation % Assay  
pH(± 0.2) 2.3 98.44 
 2.5 99.67 
 2.7 101.03 
Wave length  
(± 2 nm) 
213 98.72 
 215 99.67 
 217 99.34 
 
Repeatability (Intraday precision) 
Six consecutive recording of absorbance at 215 nm of the sample 
from the same homogeneous mixture at working concentration 
showed % RSD less than 2 concerning % assay for the drug which 
indicate that the method developed is method precise by the test of 
repeatability and hence can be understood that the method gives 
consistently reproducible results (Table 2). 
Linearity 
Standard solutions of Solifenacin succinate at different concentrations 
level (50%, 75%, 100%, 125% and 150%) were prepared. Calibration 
curve was constructed by plotting the concentration level of drug versus 
corresponding absorbance at 215 nm. The results show an excellent 
correlation between absorbance and concentration level of drug within 
the concentration range (5-15µg/ml) for the drug and the results are 
given in table 3. The correlation coefficients were greater than 0.995, 
which meet the method validation acceptance criteria and hence the 
method is said to be linear in the range of 5-15µg/ml. 
Accuracy 
Accuracy was determined by means of recovery experiments, by 
the determination of % mean recovery of sample at three 
different levels (50-150%). At each level, three determinations 
were performed. Percent mean recovery was calculated as 
shown in table 4. The accepted limits of recovery are 98% - 
102% and all observed data are within the required range which 
indicates good recovery values and hence the accuracy of the 
method developed. 
Robustness 
The robustness of an analytical method is a measure of its capacity 
to remain unaffected by small but deliberate variations in method 
parameters and provides an indication of its reliability during 
normal usage. It is concluded that the method is robust as it is found 
that the % RSD is less than 2 for the drug concerning % assay 
despite deliberate variations done concerning pH ± 0.2 and 
detection wavelength ± 2 nm (Table 5). 
Sensitivity 
The sensitivity of measurement of Solifenacin succinate by use of the 
proposed method was estimated in terms of the limit of quantitation 
(LOQ), limit of detection (LOD) and Sandell’s sensitivity. The limit of 
detection (LOD) and limit of quantitiation (LOQ) were found to be 
1.106µg/ml and 3.35µg/ml respectively. Optical characteristics and 
validation parameters results are summarized in table 6. 
  
Table 6: Optical characteristics and validation parameters of Solifenacin succinate 
Parameters Results 
Detection wavelength (nm) 215 
Beer’s Law limits (µg/ml) 5-15 
Sandell’s sensitivity (µg/cm2/0.001 absorbance unit) 0.05 
Regression equation (y = mx+c) y=0.0328x-0.020 
Correlation coefficient (r2) 0.997 
Slope (m) 0.0328 
Intercept (c) -0.020 
% Relative Standard Deviation (% RSD) System precision 0.43 
(% RSD) Intra-day precision 1.27 
(% RSD) Inter-day precision  
Accuracy (% Mean Recovery)  
 50 % Level 98.38 
 100 % Level 101.45 
 150 % Level 99.20 
LOD (µg/ml) 1.106 
LOQ (µg/ml) 3.35 
Robustness  
pH(± 0.2) (% RSD) ≤ 2 
Wavelength (± 2 nm) (% RSD) ≤ 2 
 
CONCLUSION 
A cheap and a rapid UV spectrophotometric method was developed 
and validated for the quantitative estimation of Solifenacin succinate 
in tablets as per ICH guidelines. The developed method resulted in 
Solifenacin succinate exhibiting linearity in the range 5-15 μg/ml. 
The precision is exemplified by relative standard deviation of 1.27%. 
Percentage Mean recovery was found to be in the range of 98-102, 
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during accuracy studies. The limit of detection (LOD) and limit of 
quantitiation (LOQ) were found to be 1.106µg/ml and 3.35 µg/ml 
respectively. Accordingly it is concluded that the developed UV 
spectrophotometric method is accurate, precise, linear and robust 
and therefore the method can be used for the routine analysis of 
Solifenacin succinate in tablets in various pharmaceutical industries. 
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